| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1039138887 |
| P356 | DOI | 10.2165/00148581-200305090-00002 |
| P698 | PubMed publication ID | 12956616 |
| P50 | author | Nancy M. Petry | Q44870852 |
| P2093 | author name string | Robert H Pietrzak | |
| George T Ladd | |||
| P2860 | cites work | Study 329 | Q20746326 |
| Prevalence, assessment, and treatment of pathological gambling: a review | Q28141997 | ||
| Patterns and correlates of Gamblers Anonymous attendance in pathological gamblers seeking professional treatment | Q28183554 | ||
| An outcome study of Gamblers Anonymous | Q28291926 | ||
| Adolescents with gambling problems: from research to treatment. | Q30336262 | ||
| Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design | Q33180244 | ||
| Mood stabilizers in children and adolescents | Q33608992 | ||
| Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling | Q33948583 | ||
| Opiate antagonists in children and adolescents | Q34120061 | ||
| A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling | Q34135868 | ||
| Spotlight on fluvoxamine in anxiety disorders in children and adolescents | Q34515237 | ||
| The prevention of gambling problems in youth: a conceptual framework | Q34720120 | ||
| How treatments for pathological gambling can be informed by treatments for substance use disorders | Q34861212 | ||
| Effectiveness of pharmacotherapy for pathological gambling: a chart review | Q35065699 | ||
| Suicidal ideation and suicide attempts in treatment-seeking pathological gamblers. | Q36096840 | ||
| Prevalence of pathological gambling and related problems among college students in the Quebec metropolitan area | Q39395406 | ||
| Pulse intravenous clomipramine for depressed adolescents: double-blind, controlled trial | Q39456259 | ||
| Juvenile gambling in North America: an analysis of long term trends and future prospects | Q40547662 | ||
| Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis | Q60142213 | ||
| Pathological gambling: estimating prevalence and group characteristics | Q68101051 | ||
| Treatment of pathological gambling with clomipramine | Q68109459 | ||
| Impotence associated with compulsive gambling | Q69752719 | ||
| Affective disorders among pathological gamblers seeking treatment | Q71254283 | ||
| Treatment of elective mutism with fluoxetine: a double-blind, placebo-controlled study | Q72807615 | ||
| Naltrexone for alcohol abuse | Q72990168 | ||
| Impulsivity predicts problem gambling in low SES adolescent males | Q73291395 | ||
| Gambling and alcohol use among youth: influences of demographic, socialization, and individual factors | Q73340012 | ||
| A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling | Q73794738 | ||
| Naltrexone in the treatment of pathological gambling and alcohol dependence | Q74290952 | ||
| Cognitive treatment of pathological gambling | Q77393916 | ||
| Short-term single-blind fluvoxamine treatment of pathological gambling | Q77646710 | ||
| A prospective study of youth gambling behaviors | Q77883549 | ||
| Social, psychological and physical consequences of pathological gambling in Sweden | Q86746560 | ||
| Evaluation of a prevention program for pathological gambling among adolescents | Q86813204 | ||
| Empirical measures vs. perceived gambling severity among youth: why adolescent problem gamblers fail to seek treatment | Q40583571 | ||
| An open-label study of citalopram in the treatment of pathological gambling | Q40661279 | ||
| Psychiatric comorbidity in pathological gambling: a critical review | Q40867539 | ||
| Are impulse-control disorders related to bipolar disorder? | Q41127483 | ||
| Medical approaches to gambling issues--I: The medical condition. | Q41150621 | ||
| Naltrexone in autistic children: a double-blind and placebo-controlled study | Q41987940 | ||
| Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder | Q42627601 | ||
| Comparison of response to a selective serotonin reuptake inhibitor in children, adolescents, and adults with posttraumatic stress disorder | Q42676415 | ||
| Predictors of lottery gambling among American college students | Q43490824 | ||
| A retrospective study of citalopram in adolescents with depression | Q43661451 | ||
| Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial | Q43661536 | ||
| Clomipramine versus haloperidol in the treatment of autistic disorder: a double-blind, placebo-controlled, crossover study | Q43689734 | ||
| Long-term experience with citalopram in the treatment of adolescent OCD. | Q43704784 | ||
| Comparison of problem-gambling and non-problem-gambling youths seeking treatment for marijuana abuse | Q43793101 | ||
| Alcohol and gambling pathology among U.S. adults: prevalence, demographic patterns and comorbidity | Q43795257 | ||
| Fluorine magnetic resonance spectroscopy measurement of brain fluvoxamine and fluoxetine in pediatric patients treated for pervasive developmental disorders | Q43977647 | ||
| Citalopram treatment for impulsive aggression in children and adolescents: an open pilot study | Q43996319 | ||
| A pilot placebo-controlled study of fluvoxamine for pathological gambling. | Q44015745 | ||
| Lithium and valproate treatment of pathological gambling: a randomized single-blind study. | Q44080281 | ||
| Pathological gambling. Current status and new treatments | Q44085820 | ||
| The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers | Q44366737 | ||
| Measuring pathological gambling in children: The case of fruit machines in the U.K. | Q45955420 | ||
| Gambling and correlates of gambling among Minnesota public school students | Q46384207 | ||
| Prevalence of gambling among Minnesota public school students in 1992 and 1995. | Q46931507 | ||
| Developing the DSM-IV-DSM-IV criteria to identify adolescent problem gambling in non-clinical populations | Q47368350 | ||
| Combination treatment with clomipramine and selective serotonin reuptake inhibitors for obsessive-compulsive disorder in children and adolescents | Q47931364 | ||
| Motivational enhancement and self-help treatments for problem gambling | Q48681255 | ||
| Prevalence estimates of adolescent gambling: a comparison of the SOGS-RA, DSM-IV-J, and the GA 20 questions | Q48720366 | ||
| Cognitive and behavioral treatment of pathological gambling: a controlled study | Q48737738 | ||
| Paroxetine open-label treatment of pediatric outpatients with obsessive-compulsive disorder | Q48742537 | ||
| Pathological gambling among high school students | Q48968313 | ||
| Dispositional predictors of problem gambling in male adolescents. | Q50919483 | ||
| A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. | Q50924850 | ||
| Taking chances: problem gamblers and mental health disorders--results from the St. Louis Epidemiologic Catchment Area Study. | Q51992818 | ||
| Treatment of pathological gambling with carbamazepine. | Q52026507 | ||
| An outcome study of an inpatient treatment program for pathological gamblers. | Q52091652 | ||
| Familial and social influences on juvenile gambling behavior. | Q52101774 | ||
| Cognitive-behavioral treatment for adolescent pathological gamblers. | Q52217566 | ||
| Evaluation of patients treated for pathological gambling in a combined alcohol, substance abuse and pathological gambling treatment unit using the Addiction Severity Index. | Q52265742 | ||
| The prevalence and impact of major life stressors among pathological gamblers. | Q52267615 | ||
| Gambling behavior of Louisiana students in grades 6 through 12. | Q52277920 | ||
| Pathological gambling among adolescents: Massachusetts Gambling Screen (MAGS). | Q52303508 | ||
| Alcoholism, drug abuse, and gambling. | Q52493129 | ||
| Lithium and lady luck; use of lithium carbonate in compulsive gambling. | Q54298197 | ||
| P433 | issue | 9 | |
| P304 | page(s) | 583-595 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Pediatric Drugs | Q15767256 |
| P1476 | title | Disordered gambling in adolescents : epidemiology, diagnosis, and treatment | |
| P478 | volume | 5 |
| Q35083734 | Age of first arrest varies by gambling status in a cohort of young adults |
| Q30493846 | BRAIN MYELINATION IN PREVALENT NEUROPSYCHIATRIC DEVELOPMENTAL DISORDERS: PRIMARY AND COMORBID ADDICTION. |
| Q40153438 | Epidemiology of youth gambling problems in Canada: a national prevalence study |
| Q36608914 | Executive function abnormalities in pathological gamblers |
| Q24679365 | Medication management of pathological gambling |
Search more.